Anti-angiogenic therapy for ovarian cancer

Angiogenesis is a known hallmark in cancer and plays a crucial role in ovarian cancer carcinogenesis and invasion. Anti- angiogenic agents are active in ovarian cancer treatment either as monotherapy or combined with chemotherapy, immunotherapy or poly ADP ribose polymerase (PARP) inhibitors. We rev...

Descripción completa

Detalles Bibliográficos
Autores principales: García García, Yolanda, Marín Alcalá, Maria, Martínez Vila, Clara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573465/
https://www.ncbi.nlm.nih.gov/pubmed/33240446
http://dx.doi.org/10.1016/j.ejcsup.2020.02.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573465/
https://www.ncbi.nlm.nih.gov/pubmed/33240446
http://dx.doi.org/10.1016/j.ejcsup.2020.02.003

Ejemplares similares